DRTX Durata Therapeutics, Inc. $DRTX Company Overview
Stock Message Board Recent Posts http://investorshangout.com/search?q=DRTX&...mp;yt0=Go!
Last Updated: 08/04/2014 21:29:08
Current Price and Quotes
Last Price 15.17
Previous Close 12.80 Open 14.09
Daily Range 13.85 - 15.26 52wk Range 7.73 - 18.17
Volume 1,450,115 Dividend N/A
Average Vol (3m) 383,621 Yield N/A
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 37,317 51,695 30,133 4,818
Sales, General and Admin. 18,602 9,788 4,305 2,777
Non-Recurring Items 1,053 1,097 1,121 6,300
Other - - - -
Operating Income (56,972) (62,580) (35,559) (13,895)
Income From Continuing Operations
Add'l Income/Expense Items (1,665) 41 15 3
Earnings Before Interest and Tax (58,637) (62,539) (35,544) (13,892)
Interest Expense 2,226 - - -
Earnings Before Tax (60,863) (62,539) (35,544) (13,892)
Income Tax 1,278 - (2,511) (2,878)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (64,369) (62,539) (33,033) (11,014)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (62,141) (62,539) (33,033) (11,014)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (62,141) (62,539) (33,033) (11,014)
Recent News
Aug 1, 2014 The Zacks Analyst Blog Highlights: AbbVie, Shire, ARIAD Pharmaceuticals, ImmunoGen and Durata Therapeutics
Jul 31, 2014 Durata Therapeutics to Report Second Quarter 2014 Financial Results on August 7, 2014
Jul 30, 2014 Durata Therapeutics Enters Into an Exclusive License and Supply Agreement With Angelini to Commercialize Dalbavancin in Certain European Territories, Russia and Turkey
Jul 18, 2014 Durata Therapeutics Announces the U.S. Launch of DALVANCE(TM)
Jun 17, 2014 Durata Therapeutics to Present at Upcoming Investor Conferences
Jun 4, 2014 New England Journal of Medicine Publishes Data From Durata Therapeutics' Discover Program
May 23, 2014 FDA Approves Durata Therapeutics' DALVANCE(TM) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Caused by Susceptible Gram-Positive Bacteria, Including MRSA, in Adults
May 21, 2014 Watch List for Equities Hitting New High -- Research on SanDisk, Universal Health Services, Sesa Sterlite and Durata Therapeutics
May 15, 2014 Clinical Trial Updates, Leadership Appointments, and Earnings Results - Analyst Notes on Tesaro, Novavax, Vanda, Insmed and Durata
May 13, 2014 Durata Therapeutics Presents Six Dalbavancin Posters at the 24th Annual ECCMID Meeting
1
2
next >
DRTX Durata Therapeutics, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=DRTX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/DRTX/quote
Stock Chart http://www.otcmarkets.com/stock/DRTX/chart
Company Info http://www.otcmarkets.com/stock/DRTX/company-info
Recent News http://www.otcmarkets.com/stock/DRTX/news
Financials http://www.otcmarkets.com/stock/DRTX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/DRTX/filings
Short Sales http://www.otcmarkets.com/stock/DRTX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/DRTX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/DRTX/research
Summary http://finance.yahoo.com/q?s=DRTX
Historical Prices http://finance.yahoo.com/q/hp?s=DRTX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=DRTX
Basic Chart http://finance.yahoo.com/q/bc?s=DRTX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=DRTX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=DRTX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=DRTX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=DRTX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=DRTX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=DRTX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=DRTX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=DRTX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=DRTX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=DRTX
Balance Sheet http://finance.yahoo.com/q/bs?s=DRTX
Cash Flow http://finance.yahoo.com/q/cf?s=DRTX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/DRTX
Market Watch http://www.marketwatch.com/investing/stock/DRTX
Bloomberg http://www.bloomberg.com/quote/DRTX:US
Morningstar http://quotes.morningstar.com/stock/s?t=DRTX
Bussinessweek http://investing.businessweek.com/research/st...icker=DRTX
Barchart http://www.barchart.com/quotes/stocks/DRTX
OTC Short Report http://otcshortreport.com/index.php?index=DRTX
Investopedia http://www.investopedia.com/markets/stocks/DRTX/?wa=0
Stock Message Board Recent Posts http://investorshangout.com/search?q=DRTX&...mp;yt0=Go!
Last Updated: 08/04/2014 21:29:08
Current Price and Quotes
Last Price 15.17
Previous Close 12.80 Open 14.09
Daily Range 13.85 - 15.26 52wk Range 7.73 - 18.17
Volume 1,450,115 Dividend N/A
Average Vol (3m) 383,621 Yield N/A
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 37,317 51,695 30,133 4,818
Sales, General and Admin. 18,602 9,788 4,305 2,777
Non-Recurring Items 1,053 1,097 1,121 6,300
Other - - - -
Operating Income (56,972) (62,580) (35,559) (13,895)
Income From Continuing Operations
Add'l Income/Expense Items (1,665) 41 15 3
Earnings Before Interest and Tax (58,637) (62,539) (35,544) (13,892)
Interest Expense 2,226 - - -
Earnings Before Tax (60,863) (62,539) (35,544) (13,892)
Income Tax 1,278 - (2,511) (2,878)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (64,369) (62,539) (33,033) (11,014)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (62,141) (62,539) (33,033) (11,014)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (62,141) (62,539) (33,033) (11,014)
Recent News
Aug 1, 2014 The Zacks Analyst Blog Highlights: AbbVie, Shire, ARIAD Pharmaceuticals, ImmunoGen and Durata Therapeutics
Jul 31, 2014 Durata Therapeutics to Report Second Quarter 2014 Financial Results on August 7, 2014
Jul 30, 2014 Durata Therapeutics Enters Into an Exclusive License and Supply Agreement With Angelini to Commercialize Dalbavancin in Certain European Territories, Russia and Turkey
Jul 18, 2014 Durata Therapeutics Announces the U.S. Launch of DALVANCE(TM)
Jun 17, 2014 Durata Therapeutics to Present at Upcoming Investor Conferences
Jun 4, 2014 New England Journal of Medicine Publishes Data From Durata Therapeutics' Discover Program
May 23, 2014 FDA Approves Durata Therapeutics' DALVANCE(TM) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Caused by Susceptible Gram-Positive Bacteria, Including MRSA, in Adults
May 21, 2014 Watch List for Equities Hitting New High -- Research on SanDisk, Universal Health Services, Sesa Sterlite and Durata Therapeutics
May 15, 2014 Clinical Trial Updates, Leadership Appointments, and Earnings Results - Analyst Notes on Tesaro, Novavax, Vanda, Insmed and Durata
May 13, 2014 Durata Therapeutics Presents Six Dalbavancin Posters at the 24th Annual ECCMID Meeting
1
2
next >
DRTX Durata Therapeutics, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=DRTX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/DRTX/quote
Stock Chart http://www.otcmarkets.com/stock/DRTX/chart
Company Info http://www.otcmarkets.com/stock/DRTX/company-info
Recent News http://www.otcmarkets.com/stock/DRTX/news
Financials http://www.otcmarkets.com/stock/DRTX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/DRTX/filings
Short Sales http://www.otcmarkets.com/stock/DRTX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/DRTX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/DRTX/research
Summary http://finance.yahoo.com/q?s=DRTX
Historical Prices http://finance.yahoo.com/q/hp?s=DRTX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=DRTX
Basic Chart http://finance.yahoo.com/q/bc?s=DRTX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=DRTX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=DRTX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=DRTX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=DRTX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=DRTX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=DRTX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=DRTX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=DRTX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=DRTX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=DRTX
Balance Sheet http://finance.yahoo.com/q/bs?s=DRTX
Cash Flow http://finance.yahoo.com/q/cf?s=DRTX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/DRTX
Market Watch http://www.marketwatch.com/investing/stock/DRTX
Bloomberg http://www.bloomberg.com/quote/DRTX:US
Morningstar http://quotes.morningstar.com/stock/s?t=DRTX
Bussinessweek http://investing.businessweek.com/research/st...icker=DRTX
Barchart http://www.barchart.com/quotes/stocks/DRTX
OTC Short Report http://otcshortreport.com/index.php?index=DRTX
Investopedia http://www.investopedia.com/markets/stocks/DRTX/?wa=0
